Question 1

FDAはJohnson & Johnsonに何を販売することを認可しましたか？

Accepted Answer

The FDA granted De Novo marketing authorization for the OTTAVA Robotic Surgical System, cleared for ten general surgery procedures in the upper abdomen, including cholecystectomy, appendectomy, gastric sleeve, and Roux-en-Y gastric bypass.

Question 2

OTTAVAが他の手術用ロボットと異なる点は何ですか？

Accepted Answer

According to Johnson & Johnson, OTTAVA integrates its four robotic arms directly into the operating table rather than using carts or booms, a design the company says occupies 30 to 50 percent less space than traditional systems.

Question 3

病院はいつOTTAVAを使用できるようになりますか？

Accepted Answer

Johnson & Johnson said it will launch the system commercially with select US customers first, while pursuing additional approved uses and clearance in other countries; a US clinical trial for inguinal hernia repair is ongoing.

Johnson & Johnson

Johnson & Johnson、FDAからロボット手術装置の承認を取得

鋭い要約を。
毎日。

Johnson & Johnson

Johnson & Johnson、FDAからロボット手術装置の承認を取得

鋭い要約を。毎日。

鋭い要約を。
毎日。